Weide Viva Stichprobe dose escalation study definition Kontraktion Falten Freiwillig
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology
Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol | BMJ Open
The phases of preclinical and clinical trials
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
PDF] Dose Escalation Methods in Phase I Cancer Clinical Trials | Semantic Scholar
Early phase clinical trials to identify optimal dosing and safety - ScienceDirect
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial - eClinicalMedicine
Sequential dose-escalation study design | Download Scientific Diagram
Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
On Biostatistics and Clinical Trials: Early Phase Trial to Find Maximal Tolerated Dose (MTD) - 3+3, CRM, and BOIN Designs
Cureus | Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases | Article
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text
The Classic 3 + 3 Design in Dose-finding Clinical Trials and Its Alternatives | Genpro Research
Schematic overview of the dose escalation cohorts. Three to nine... | Download Scientific Diagram
Roche Template
Phase 1 clinical trials: Designs and considerations
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study. - Abstract - Europe PMC
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era - ScienceDirect
Dose escalation. The dose escalation was performed in both intra and... | Download Scientific Diagram
Phase 1 clinical trials: Designs and considerations